ATE217863T1 - Arylsulfonylaminohydroxamsäurederivate - Google Patents
ArylsulfonylaminohydroxamsäurederivateInfo
- Publication number
- ATE217863T1 ATE217863T1 AT98305959T AT98305959T ATE217863T1 AT E217863 T1 ATE217863 T1 AT E217863T1 AT 98305959 T AT98305959 T AT 98305959T AT 98305959 T AT98305959 T AT 98305959T AT E217863 T1 ATE217863 T1 AT E217863T1
- Authority
- AT
- Austria
- Prior art keywords
- aryl
- acid derivatives
- arylsulfonylaminohydroxamic
- arylsulfonylaminohydroxamic acid
- angiogenisis
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 206010014989 Epidermolysis bullosa Diseases 0.000 abstract 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010039705 Scleritis Diseases 0.000 abstract 1
- 206010040047 Sepsis Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000036269 ulceration Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5520897P | 1997-08-08 | 1997-08-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE217863T1 true ATE217863T1 (de) | 2002-06-15 |
Family
ID=21996365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98305959T ATE217863T1 (de) | 1997-08-08 | 1998-07-27 | Arylsulfonylaminohydroxamsäurederivate |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0895988B1 (de) |
| JP (1) | JPH11116549A (de) |
| AT (1) | ATE217863T1 (de) |
| BR (1) | BR9803128A (de) |
| CA (1) | CA2244501C (de) |
| DE (1) | DE69805473T2 (de) |
| DK (1) | DK0895988T3 (de) |
| ES (1) | ES2176913T3 (de) |
| PT (1) | PT895988E (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PA8469301A1 (es) | 1998-04-10 | 2000-09-29 | Pfizer Prod Inc | Procedimientos para la preparacion de acidos hidroxamicos. |
| PA8469601A1 (es) | 1998-04-10 | 2000-09-29 | Pfizer Prod Inc | Procedimiento para alquilar sulfonamidas impedidas estericamente |
| GT199900044A (es) * | 1998-04-10 | 2000-09-14 | Procedimientos para preparar haluros de fenoxifenilsulfonilo. | |
| WO2000058280A1 (en) * | 1999-03-26 | 2000-10-05 | Shionogi & Co., Ltd. | Carbocyclic sulfonamide derivatives |
| EP1041072B1 (de) * | 1999-03-31 | 2003-07-16 | Pfizer Products Inc. | Dioxocyclopentylhydroxamsäure |
| IL138686A0 (en) | 1999-10-01 | 2001-10-31 | Pfizer Prod Inc | α- SULFONYLAMINO HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISORDERS |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
| JP2003528082A (ja) | 2000-03-21 | 2003-09-24 | ザ プロクター アンド ギャンブル カンパニー | ニフッ化酪酸メタロプロテアーゼ阻害物質 |
| EP1265864A1 (de) | 2000-03-21 | 2002-12-18 | The Procter & Gamble Company | Heterozyklische seitenkette enhaltende, n-substituierte metalloproteaseinhibitoren |
| US6548667B2 (en) * | 2000-04-07 | 2003-04-15 | Samsung Electronics Co. Ltd. | Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| BR0207297A (pt) | 2001-02-15 | 2005-04-19 | King Pharmaceuticals Inc | Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo |
| CA2440419C (en) * | 2001-03-14 | 2010-05-04 | Novartis Ag | Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| MY143582A (en) | 2001-06-26 | 2011-05-31 | Amgent Fremont Inc | Antibodies to opgl |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| DE60231425D1 (de) * | 2001-11-13 | 2009-04-16 | Shiseido Co Ltd | Azabicycloverbindung, matrixmetallproteaseinhibitor und zubereitung für haut |
| PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| CA2471814C (en) | 2001-12-27 | 2011-03-15 | Sumitomo Pharmaceuticals Co., Ltd. | Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| MXPA05007019A (es) | 2002-12-30 | 2005-08-18 | Amgen Inc | Terapia de combinacion con factores co-estimuladores. |
| GB0326546D0 (en) * | 2003-11-14 | 2003-12-17 | Amersham Plc | Inhibitor imaging agents |
| DE602004026629D1 (de) | 2003-12-15 | 2010-05-27 | Japan Tobacco Inc | Cyclopropanderivate und ihre pharmazeutische verwendung |
| ZA200605247B (en) * | 2003-12-15 | 2007-10-31 | Japan Tobacco Inc | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10501806A (ja) * | 1994-06-22 | 1998-02-17 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
| US5863949A (en) * | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| US6153609A (en) * | 1996-08-23 | 2000-11-28 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
-
1998
- 1998-07-27 AT AT98305959T patent/ATE217863T1/de not_active IP Right Cessation
- 1998-07-27 DE DE69805473T patent/DE69805473T2/de not_active Expired - Fee Related
- 1998-07-27 EP EP98305959A patent/EP0895988B1/de not_active Expired - Lifetime
- 1998-07-27 ES ES98305959T patent/ES2176913T3/es not_active Expired - Lifetime
- 1998-07-27 PT PT98305959T patent/PT895988E/pt unknown
- 1998-07-27 DK DK98305959T patent/DK0895988T3/da active
- 1998-08-03 JP JP10218971A patent/JPH11116549A/ja active Pending
- 1998-08-06 CA CA002244501A patent/CA2244501C/en not_active Expired - Fee Related
- 1998-08-10 BR BR9803128-7A patent/BR9803128A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0895988A1 (de) | 1999-02-10 |
| PT895988E (pt) | 2002-09-30 |
| CA2244501A1 (en) | 1999-02-08 |
| DE69805473D1 (de) | 2002-06-27 |
| JPH11116549A (ja) | 1999-04-27 |
| CA2244501C (en) | 2003-03-18 |
| ES2176913T3 (es) | 2002-12-01 |
| BR9803128A (pt) | 2000-05-02 |
| DK0895988T3 (da) | 2002-09-09 |
| EP0895988B1 (de) | 2002-05-22 |
| DE69805473T2 (de) | 2003-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE217863T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
| EP0818442A3 (de) | Cyclische Sulphonderivate als Metalloproteinase-Inhibitoren und zur Hemmung der Produktion von Tumornekrosefaktor | |
| MY113586A (en) | Aylsulfonylamino hydroxamic acid derivatives | |
| CA2218503A1 (en) | Arylsulfonyl hydroxamic acid derivatives | |
| FR2744010B1 (fr) | Procede de fabrication d'implants osseux | |
| CA2349227A1 (en) | Substituted 2-phenylbenzimidazoles, the production thereof and their use | |
| MY121754A (en) | Arylsulfonylamino hydroxamic acid derivatives | |
| AP9801174A0 (en) | Cyclic sulfone derivatives. | |
| ATE223215T1 (de) | Inhibitoren der fettsäuresynthese als antimikrobielle mittel | |
| MX9804793A (es) | Acidos arilsulfonamido-hidroxamicos alfa-sustituidos como inhibidores de factor de necrosis tumoral-alfa y de metaloproteinasa de matriz. | |
| EA199900641A1 (ru) | Производные арилсульфонилгидроксамовой кислоты | |
| ID16144A (id) | Turunan asam hidroksamik baru yang berguna untuk perawatan penyakit yang berhubungan dengan degradasi jaringan penghubung | |
| FI920771A0 (fi) | Hydroxylamidbaserade kollagenasinhibitorer. | |
| WO2003007719A1 (fr) | Nettoyants, systeme de nettoyage, agents de blanchiment et compositions pour la preservation de l'environnement | |
| ATE272398T1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| MX9707692A (es) | Acido aza bisfosfonicos herbicidas y composiciones que los contienen. | |
| CA2340138A1 (en) | 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases | |
| CA2254731A1 (en) | Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids | |
| EP1152004A4 (de) | Derivate der phosphonsäure zur inhibierung von carboxypeptidase b | |
| WO2000015208A3 (en) | New use of immunosupressants for mmp-mediated diseases | |
| DK0826681T3 (da) | Epoxyravsyrederivater | |
| CA2253796A1 (en) | Inhibition of matrix metalloproteases by acetylene containing compounds | |
| TNSN04055A1 (fr) | Formes cristallines anhydres de gabapentine | |
| PL296314A2 (en) | Method of obtaining novel derivatives of tridiazinones | |
| CA2397960A1 (en) | Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |